Roundview Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Buy
13,019
+26
+0.2% +$9.64K 0.3% 80
2026
Q1
$3.52M Sell
12,993
-4,986
-28% -$1.48M 0.22% 104
2025
Q4
$5.94M Buy
17,979
+20
+0.1% +$6.78K 0.37% 65
2025
Q3
$6.2M Buy
17,959
+2,070
+13% +$626K 0.39% 57
2025
Q2
$4.96M Sell
15,889
-3,445
-18% -$1.32M 0.33% 69
2025
Q1
$10.1M Sell
19,334
-4,105
-18% -$2.1M 0.73% 30
2024
Q4
$11.9M Sell
23,439
-1,240
-5% -$705K 0.83% 25
2024
Q3
$14.4M Sell
24,679
-106
-0.4% -$60K 1.05% 19
2024
Q2
$12.6M Sell
24,785
-2,625
-10% -$1.29M 0.99% 19
2024
Q1
$13.6M Buy
27,410
+1,161
+4% +$590K 1.11% 17
2023
Q4
$13.8M Buy
26,249
+235
+0.9% +$125K 1.27% 14
2023
Q3
$13.1M Buy
26,014
+985
+4% +$485K 1.32% 13
2023
Q2
$12M Buy
25,029
+2,701
+12% +$1.32M 1.17% 17
2023
Q1
$10.6M Buy
22,328
+514
+2% +$248K 1.1% 16
2022
Q4
$11.6M Buy
21,814
+457
+2% +$242K 1.32% 12
2022
Q3
$10.8M Buy
21,357
+271
+1% +$143K 1.36% 12
2022
Q2
$10.8M Sell
21,086
-126
-0.6% -$63.3K 1.3% 12
2022
Q1
$10.8M Buy
21,212
+434
+2% +$209K 1.11% 15
2021
Q4
$10.4M Buy
20,778
+1,133
+6% +$513K 1.04% 21
2021
Q3
$7.68M Buy
19,645
+1,870
+11% +$775K 0.85% 24
2021
Q2
$7.12M Buy
17,775
+1,187
+7% +$473K 0.79% 25
2021
Q1
$6.17M Buy
16,588
+168
+1% +$58.2K 0.78% 27
2020
Q4
$5.76M Buy
16,420
+663
+4% +$222K 0.79% 30
2020
Q3
$4.91M Sell
15,757
-88
-0.6% -$27K 0.77% 29
2020
Q2
$4.67M Buy
15,845
+504
+3% +$144K 0.79% 28
2020
Q1
$3.83M Buy
15,341
+2,180
+17% +$600K 0.81% 30
2019
Q4
$3.87M Buy
13,161
+1,230
+10% +$322K 0.74% 31
2019
Q3
$2.59M Buy
11,931
+325
+3% +$78.4K 0.56% 51
2019
Q2
$2.83M Buy
11,606
+580
+5% +$140K 0.64% 41
2019
Q1
$2.73M Buy
11,026
+9
+0.1% +$2.29K 0.65% 47
2018
Q4
$2.75M Buy
11,017
+145
+1% +$38.3K 0.77% 35
2018
Q3
$2.89M Buy
10,872
+10
+0.1% +$2.6K 0.71% 36
2018
Q2
$2.67M Buy
10,862
+70
+0.6% +$16.8K 0.7% 37
2018
Q1
$2.31M Sell
10,792
-550
-5% -$126K 0.65% 45
2017
Q4
$2.5M Buy
11,342
+116
+1% +$24.6K 0.65% 45
2017
Q3
$2.2M Sell
11,226
-341
-3% -$65.9K 0.63% 47
2017
Q2
$2.15M Buy
11,567
+14
+0.1% +$2.46K 0.63% 51
2017
Q1
$1.9M Sell
11,553
-131
-1% -$21.5K 0.59% 58
2016
Q4
$1.87M Buy
11,684
+540
+5% +$80.7K 0.6% 51
2016
Q3
$1.56M Sell
11,144
-365
-3% -$51.1K 0.55% 54
2016
Q2
$1.63M Hold
11,509
0.6% 55
2016
Q1
$1.48M Sell
11,509
-250
-2% -$29.6K 0.55% 58
2015
Q4
$1.38M Buy
11,759
+1,294
+12% +$151K 0.55% 58
2015
Q3
$1.21M Buy
10,465
+30
+0.3% +$3.59K 0.52% 59
2015
Q2
$1.27M Sell
10,435
-545
-5% -$64.5K 0.48% 66
2015
Q1
$1.3M Hold
10,980
0.51% 62
2014
Q4
$1.11M Sell
10,980
-80
-0.7% -$7.58K 0.46% 71
2014
Q3
$954K Hold
11,060
0.43% 69
2014
Q2
$904K Buy
11,060
+1,040
+10% +$81.8K 0.37% 89
2014
Q1
$822K Hold
10,020
0.4% 77
2013
Q4
$755K Sell
10,020
-300
-3% -$21.6K 0.35% 86
2013
Q3
$739K Hold
10,320
0.38% 80
2013
Q2
$676K Buy
+10,320
New +$642K 0.42% 74

Other funds holding UNH

Roundview Capital's UNH Position: Q2 2026 in Review

Roundview Capital increased its UnitedHealth (UNH) stake by 0.2% in Q2 2026, buying an estimated $9.64K and bringing the position to 13,019 shares worth $5.41M. The position accounts for 0.3% of the portfolio, ranked #80.

Roundview Capital first reported a position in UNH in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q3 2024. 1,742 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Roundview Capital held 13,019 shares of UnitedHealth worth $5.41M as of Q2 2026.
  • Roundview Capital bought 26 UnitedHealth shares in Q2 2026, an estimated $9.64K.
  • UnitedHealth made up 0.3% of Roundview Capital's portfolio in Q2 2026, its #80 holding.
  • Roundview Capital first reported a position in UnitedHealth in Q2 2013 and has held it in 53 quarters since.
  • Roundview Capital's UnitedHealth position peaked at $14.4M in Q3 2024.
  • 1,742 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.